Quick Answer: Zepbound may cause burping and gas due to its effect of slowing gastric emptying, though burping is not specifically listed as a common adverse effect in FDA prescribing information
Segments - by Product Type (Synthetic, Biotechnological, and Others), Application (Diabetes Treatment, Weight Management, Cardiovascular Diseases, and Others), End-User (Pharmaceutical Companies, Research Institutes, Contract Manufacturing Organizations, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2025-2034 + Read More The global Semaglutide API market was valued at $4.8 billion in 2025 and is projected to expand at a compound annual growth rate (CAGR) of 16.2% from 2026 to 2034, reaching an estimated $18.6 billion by 2034, driven by unprecedented demand for glucagon-like peptide-1 (GLP-1) receptor agonist therapies across diabetes management, obesity treatment, and cardiovascular risk reduction indications
Frequently Asked Questions (FAQ) How fast does Liposomal Glutathione work
The MHRA's Yellow Card reporting scheme continues to collect post-marketing data on such effects for all licensed medicines
But in December 2024, the FDA announced that the tirzepatide shortage had ended
